Skip to main content
Dara Aisner, MD, Pathology, Aurora, CO

DaraLiannaAisnerMD

Pathology Aurora, CO

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology, University of Colorado School of Medicine

Are you Dr. Aisner?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 52 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    12605 E 16th Ave
    Aurora, CO 80045
    Phone+1 720-848-0000

Summary

  • Dr. Dara Aisner, MD is a board certified pathologist in Aurora, Colorado. She is currently licensed to practice medicine in Colorado, Pennsylvania, and Maryland. She is affiliated with University of Colorado Hospital and UCHealth Memorial Hospital.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Molecular Genetic Pathology, 2009 - 2010
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 2004

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2010 - 2025
  • MD State Medical License
    MD State Medical License 2006 - 2010
  • PA State Medical License
    PA State Medical License 2008 - 2010
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Clinical Informatics
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Authored Content

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018

Press Mentions

  • Pursuing Precision Oncology with World-Class Custom Bioinformatic Pipelines
    Pursuing Precision Oncology with World-Class Custom Bioinformatic PipelinesSeptember 23rd, 2024
  • CU Anschutz Researchers Roll Out Antibody Test
    CU Anschutz Researchers Roll Out Antibody TestJune 9th, 2020
  • CU Cell Technologies Shared Resource Makes COVID-19 Proteins for Research, Antibody Testing
    CU Cell Technologies Shared Resource Makes COVID-19 Proteins for Research, Antibody TestingMay 29th, 2020
  • Join now to see all

Professional Memberships